Ticker >

Dr Lalchandani Labs share price

Dr Lalchandani Labs Ltd.

BSE: 541299 SECTOR: Hospital & Healthcare Services  25k   107   5

20.16
-1.06 (-5.00%)
BSE: 11 Jun 4:00 PM

Price Summary

Today's High

₹ 20.16

Today's Low

₹ 20.16

52 Week High

₹ 35

52 Week Low

₹ 15.68

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

8.74 Cr.

Enterprise Value

12.04 Cr.

No. of Shares

0.43 Cr.

P/E

14.16

P/B

0.98

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  20.56

CASH

3.1 Cr.

DEBT

6.4 Cr.

Promoter Holding

60.78 %

EPS (TTM)

₹  1.42

Sales Growth

-55.31%

ROE

-16.23 %

ROCE

-3.69%

Profit Growth

-267.45 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-55.31%
3 Year-6.18%
5 Year12.59%

Profit Growth

1 Year-267.45%
3 Year-248.81%
5 Year-242.88%

ROE%

1 Year-16.23%
3 Year1.61%
5 Year4.14%

ROCE %

1 Year-3.69%
3 Year8.08%
5 Year9.2%

Debt/Equity

0.719

Price to Cash Flow

7279.55

Interest Cover Ratio

-0.572075243939242

CFO/PAT (5 Yr. Avg.)

1.90708249064171

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 60.78 0
Sep 2023 60.78 0
Mar 2023 60.78 0
Sep 2022 60.78 0
Mar 2022 60.78 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 27.794358807934 days.
  • Company has a healthy liquidity position with current ratio of 2.07110768594575.
  • The company has a good cash flow management; CFO/PAT stands at 1.90708249064171.
  • The company has a high promoter holding of 60.78%.

 Limitations

  • The company has shown a poor profit growth of -248.810664855555% for the Past 3 years.
  • The company has shown a poor revenue growth of -6.18310344673337% for the Past 3 years.
  • Company has a poor ROE of 1.61019073022584% over the past 3 years.
  • Company has low Interest coverage ratio of -0.572075243939242.
  • Company has high debtor days of 332.440974564501.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 5.26 6.1 9.78 11.28 5.04
Total Expenditure 4.06 4.84 7.53 8.81 4.95
Operating Profit 1.2 1.27 2.25 2.47 0.09
Other Income 0.01 0 0 0 0
Interest 0.14 0.18 0.35 0.6 0.99
Depreciation 0.35 0.42 0.52 0.59 0.66
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.72 0.66 1.38 1.29 -1.56
Tax 0.19 0.19 0.37 0.35 0
Net Profit 0.53 0.47 1.01 0.93 -1.56
Adjusted EPS (Rs.) 1.23 1.09 2.33 2.15 -3.61

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 4.33 4.33 4.33 4.33 4.33
Total Reserves 3.73 4.21 5.22 6.15 4.59
Borrowings 0.6 1.46 2.64 2.62 3.32
Other N/C liabilities 0.05 0.08 0.13 0.16 0.16
Current liabilities 1.42 1.86 2.87 4.86 5.32
Total Liabilities 10.14 11.93 15.2 18.12 17.72
Assets
Net Block 3.28 3.47 5.24 5.75 5.39
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.24 0.24 0.24 0.24 0.24
Loans & Advances 0.32 0.32 0.92 1.22 1.07
Other N/C Assets 0.46 0.34 0.23 0.11 0
Current Assets 5.85 7.56 8.56 10.8 11.02
Total Assets 10.14 11.93 15.2 18.12 17.72
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.72 0.66 1.38 1.29 -1.56
Adjustment 0.35 0.42 0.69 1.07 1.54
Changes in Assets & Liabilities -1.45 -1.02 -0.57 -0.02 0.03
Tax Paid -0.07 -0.16 -0.31 -0.33 0
Operating Cash Flow -0.45 -0.1 1.19 2.01 0
Investing Cash Flow -1.95 -0.53 -2.26 -1.53 -0.2
Financing Cash Flow 3.51 0.85 1.71 0.16 -0.23
Net Cash Flow 1.12 0.23 0.64 0.64 -0.43

Corporate Actions

Investors Details

PARTICULARS Mar 2022% Sep 2022% Mar 2023% Sep 2023% Mar 2024%
promoters 60.78 60.78 60.78 60.78 60.78
anchal gupta 0.83 0.83 0.83 0.83 0.83
arjan lal chandani 55.08 55.08 55.08 55.08 55.08
mohit lal chandani 4.87 4.87 4.87 4.87 4.87
PARTICULARS Mar 2022% Sep 2022% Mar 2023% Sep 2023% Mar 2024%
investors 39.22 39.22 39.22 39.22 39.22
amit charan 5.08 5.08 5.08 5.08 5.08
harsh kapoor 3.46 3.46 - - 3.46
laxmipat dudheria 2.77 2.86 2.86 2.86 2.86
mithun securities private... - 1.11 1.85 1.85 2.31
singhi dinesh kumar huf 1.85 1.85 1.85 1.85 1.85
tushar rohitbhai pandya - 1.75 1.75 1.75 1.75
devki nandan devki nandan... - - - 1.02 -
harsh kapoor . - - 3.46 3.46 -
sachin gupta 1.11 1.11 - - -
poonam sundeep karna 1.38 - - - -
sundeep arjun karna huf 2.12 - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

  • PresentationQ2FY24 2 Nov 2023

Dr Lalchandani Labs Stock Price Analysis and Quick Research Report. Is Dr Lalchandani Labs an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Dr Lalchandani Labs and its performance over the period of time. Dr Lalchandani Labs stock price today is Rs 20.16.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Dr Lalchandani Labs cash from the operating activity was Rs 0.0012 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Dr Lalchandani Labs has a Debt to Equity ratio of 0.719 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Dr Lalchandani Labs , the EPS growth was -267.44974232787 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Dr Lalchandani Labs has OPM of 1.77373913733581 % which is a bad sign for profitability.
     
  • ROE: Dr Lalchandani Labs have a poor ROE of -16.2256726521416 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Dr Lalchandani Labs is Rs 20.16. One can use valuation calculators of ticker to know if Dr Lalchandani Labs share price is undervalued or overvalued.
Last Updated on:
Brief about Dr Lalchandani Labs
X